Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ

References

• Preti M, Van Seters M, Sideri M, Van Beurden M. Squamous vulvar intraepithelial neoplasia. Clin Obstet Gynecol. 2005;48:845–61.
   PubMedGoogle Scholar
• ISSVD. New nomenclature for vulvar disease. Obstet Gynecol. 1976;47:122–4.
   Google Scholar
• Wilkinson EJ, Kneale BL, Lynch PJ. Report of the ISSVD Terminology Committee. J Reprod Med. 1986;31:973–4.
   Web of Science ®Google Scholar
• Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med. 2005;50:807–10.
   PubMed Web of Science ®Google Scholar
• Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis. 2006;10:161–9.
   PubMedGoogle Scholar
• Wilkinson EJ, Teixeira MR. Tumors of the vulva. In: Tavassoli FA, Devilee P, (eds). Pathology and genetics of tumours of the breast and female genital organs World health organization classification of tumours. Lyon: IARC Press 2003:313–34.
   Google Scholar
• Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26(Suppl 10):K17–28.
   PubMedGoogle Scholar
• van de Nieuwenhof HP, Massuger LF, van der Avoort IA, Bekkers RL, Casparie M, Abma W, Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45:851–6.
   PubMed Web of Science ®Google Scholar
• Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol. 2001;20:16–30.
   PubMed Web of Science ®Google Scholar
• Scurry J, Campion M, Scurry B, Kim SN, Hacker N. Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia. Int J Gynecol Pathol. 2006;25:176–81.
   PubMed Web of Science ®Google Scholar
• Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol. 2000;24:429–41.
   PubMed Web of Science ®Google Scholar
• van Beurden M, de Craen AJ, de Vet HC, Blaauwgeers JL, Drillenburg P, Gallee MP, The contribution of MIB 1 in the accurate grading of vulvar intraepithelial neoplasia. J Clin Pathol. 1999;52:820–4.
   Google Scholar
• Preti M, Mezzetti M, Robertson C, Sideri M. Inter-observer variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: results of an European collaborative study. BJOG. 2000;107:594–9.
   Google Scholar
• Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol. 1992;166:1482–5.
   PubMed Web of Science ®Google Scholar
• Iversen T, Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol. 1998;91:969–72.
   PubMed Web of Science ®Google Scholar
• Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med. 2000;45:613–5.
   PubMed Web of Science ®Google Scholar
• Al-Ghamdi A, Freedman D, Miller D, Poh C, Rosin M, Zhang L, Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol. 2002;84:94–101.
   PubMed Web of Science ®Google Scholar
• Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018–22.
   PubMed Web of Science ®Google Scholar
• Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer. 2008;113(10 Suppl):2865–72.
   Google Scholar
• Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191:182–92.
   PubMed Web of Science ®Google Scholar
• Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423–8.
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994;169:235–40.
   PubMed Web of Science ®Google Scholar
• Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis. 1995;171:1026–30.
   PubMed Web of Science ®Google Scholar
• De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124:1626–36.
   PubMed Web of Science ®Google Scholar
• Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol. 2009;113:917–24.
   PubMed Web of Science ®Google Scholar
• Hillemanns P, Wang X. Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia. Gynecol Oncol. 2006;100:276–82.
   PubMed Web of Science ®Google Scholar
• Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol. 2006;30:1513–8.
   PubMed Web of Science ®Google Scholar
• Garland SM, Insinga RP, Sings HL, Haupt RM, Joura EA. Human papillomavirus infections and vulvar disease development. Cancer Epidemiol Biomarkers Prev. 2009;18:1777–84.
   PubMed Web of Science ®Google Scholar
• van Beurden M, ten Kate FJ, Smits HL, Berkhout RJ, de Craen AJ, van der Vange N, Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer. 1995;75:2879–84.
   PubMed Web of Science ®Google Scholar
• Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol. 2000;96:403–9.
   PubMed Web of Science ®Google Scholar
• Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A, Group HIVERS. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol. 2006;107:1023–8.
   PubMed Web of Science ®Google Scholar
• Khan AM, Freeman-Wang T, Pisal N, Singer A. Smoking and multicentric vulval intraepithelial neoplasia. J Obstet Gynaecol. 2009;29:123–5.
   PubMedGoogle Scholar
• Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer. 2000;82:1332–8.
   PubMed Web of Science ®Google Scholar
• Goffin F, Mayrand MH, Gauthier P, Alobaid A, Lussier C, Provencher D, High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. J Med Virol. 2006;78:814–9.
   PubMed Web of Science ®Google Scholar
• Ferenczy A, Coutlee F, Franco E, Hankins C. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ. 2003;169:431–4.
   PubMed Web of Science ®Google Scholar
• Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol. 2004;190:1241–8.
   PubMed Web of Science ®Google Scholar
• Bourgault Villada I, Moyal Barracco M, Ziol M, Chaboissier A, Barget N, Berville S, Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4(+) and CD8(+) T-cell responses. Cancer Res. 2004;64:8761–6.
   PubMed Web of Science ®Google Scholar
• Gul N, Ganesan R, Luesley DM. Characterizing T-cell response in low-grade and high-grade vulval intraepithelial neoplasia, study of CD3, CD4 and CD8 expressions. Gynecol Oncol. 2004;94:48–53.
   PubMed Web of Science ®Google Scholar
• Santegoets LA, van Seters M, Heijmans-Antonissen C, Kleinjan A, van Beurden M, Ewing PC, Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cells. Int J Cancer. 2008;123:616–22.
   PubMed Web of Science ®Google Scholar
• Singh K, Yeo Y, Honest H, Ganesan R, Luesley D. Antigen processing and correlation with immunological response in vulval intraepithelial neoplasia–a study of CD1a, CD54 and LN3 expression. Gynecol Oncol. 2006;102:489–92.
   PubMed Web of Science ®Google Scholar
• van Seters M, Beckmann I, Heijmans-Antonissen C, van Beurden M, Ewing PC, Zijlstra FJ, Disturbed patterns of immunocompetent cells in usual-type vulvar intraepithelial neoplasia. Cancer Res. 2008;68:6617–22.
   PubMed Web of Science ®Google Scholar
• Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001;20:7874–87.
   PubMed Web of Science ®Google Scholar
• Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene. 2001;20:7888–98.
   PubMed Web of Science ®Google Scholar
• van der Avoort IA, Shirango H, Hoevenaars BM, Grefte JM, de Hullu JA, de Wilde PC, Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol. 2006;25:22–9.
   PubMed Web of Science ®Google Scholar
• Hoevenaars BM, van der Avoort IA, de Wilde PC, Massuger LF, Melchers WJ, de Hullu JA, A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer. 2008;123:2767–73.
   PubMed Web of Science ®Google Scholar
• Rufforny I, Wilkinson EJ, Liu C, Zhu H, Buteral M, Massoll NA. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma. J Low Genit Tract Dis. 2005;9:108–13.
   Google Scholar
• Santos M, Montagut C, Mellado B, Garcia A, Ramon y Cajal S, Cardesa A, Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol. 2004;23:206–14.
   PubMed Web of Science ®Google Scholar
• O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13:8–15.
   PubMed Web of Science ®Google Scholar
• Nogueira MC, Guedes Neto Ede P, Rosa MW, Zettler E, Zettler CG. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res. 2006;12:153–7.
   Google Scholar
• van de Nieuwenhof HP, van Kempen LC, de Hullu JA, Bekkers RL, Bulten J, Melchers WJ, The Etiologic Role of HPV in Vulvar Squamous Cell Carcinoma Fine Tuned. Cancer Epidemiol Biomarkers Prev. 2009;18:2061–7.
   Google Scholar
• Aulmann S, Schleibaum J, Penzel R, Schirmacher P, Gebauer G, Sinn HP. Gains of chromosome region 3q26 in intraepithelial neoplasia and invasive squamous cell carcinoma of the vulva are frequent and independent of HPV status. J Clin Pathol. 2008;61:1034–7.
   Google Scholar
• Bonvicini F, Venturoli S, Ambretti S, Paterini P, Santini D, Ceccarelli C, Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma. J Med Virol. 2005;77:102–6.
   Google Scholar
• Medeiros F, Nascimento AF, Crum CP. Early vulvar squamous neoplasia: advances in classification, diagnosis, and differential diagnosis. Adv Anat Pathol. 2005;12:20–6.
   Google Scholar
• Haefner HK, Tate JE, McLachlin CM, Crum CP. Vulvar intraepithelial neoplasia: age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma. Human Pathol. 1995;26:147–54.
   Google Scholar
• Scurry J, Comparison of histological features of vulvar lichen sclerosis with and without adjacent squamous cell carcinoma. Int J Gynecol Cancer. 1997;7:192–9.
   Google Scholar
• Vilmer C, Cavelier-Balloy B, Nogues C, Trassard M, Le Doussal V. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol. 1998;19:25–31.
   PubMed Web of Science ®Google Scholar
• Eva LJ, Ganesan R, Chan KK, Honest H, Luesley DM. Differentiated-type vulval intraepithelial neoplasia has a high-risk association with vulval squamous cell carcinoma. Int J Gynecol Cancer. 2009;19:741–4.
   Google Scholar
• Eva LJ, Ganesan R, Chan KK, Honest H, Malik S, Luesley DM. Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases. J Reprod Med. 2008;53:397–401.
   PubMed Web of Science ®Google Scholar
• van Seters M, ten Kate FJ, van Beurden M, Verheijen RH, Meijer CJ, Burger MP, In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. J Clin Pathol. 2007;60:504–9.
   Google Scholar
• Pinto AP, Lin MC, Sheets EE, Muto MG, Sun D, Crum CP. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva. Gynecol Oncol. 2000;77:171–6.
   PubMedGoogle Scholar
• Hantschmann P, Sterzer S, Jeschke U, Friese K. P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. Anticancer research. 2005;25:1739–45.
   Google Scholar
• Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol. 2008;27:125–35.
   PubMed Web of Science ®Google Scholar
• McNally OM, Mulvany NJ, Pagano R, Quinn MA, Rome RM. VIN 3: a clinicopathologic review. Int J Gynecol Cancer. 2002;12:490–5.
   PubMedGoogle Scholar
• van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol. 2005;97:645–51.
   PubMed Web of Science ®Google Scholar
• van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 2008;68:131–56.
   PubMed Web of Science ®Google Scholar
• Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol. 2006;108:1361–8.
   PubMed Web of Science ®Google Scholar
• Roma AA, Hart WR. Progression of simplex (differentiated) vulvar intraepithelial neoplasia to invasive squamous cell carcinoma: a prospective case study confirming its precursor role in the pathogenesis of vulvar cancer. Int J Gynecol Pathol. 2007;26:248–53.
   Google Scholar
• Baggish MS, Sze EH, Adelson MD, Cohn G, Oates RP. Quantitative evaluation of the skin and accessory appendages in vulvar carcinoma in situ. Obstet Gynecol. 1989;74:169–74.
   Google Scholar
• Benedet JL, Wilson PS, Matisic J. Epidermal thickness and skin appendage involvement in vulvar intraepithelial neoplasia. J Reprod Med. 1991;36:608–12.
   Google Scholar
• van der Avoort IA, van der Laak JA, Paffen A, Grefte JM, Massuger LF, de Wilde PC, MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Mod Pathol. 2007;20:770–8.
   Google Scholar
• Likes WM, Stegbauer C, Hathaway D, Brown C, Tillmanns T. Use of the female sexual function index in women with vulvar intraepithelial neoplasia. Journal of sex & marital therapy. 2006;32:255–66.
   PubMed Web of Science ®Google Scholar
• Likes WM, Stegbauer C, Tillmanns T, Pruett J. Pilot study of sexual function and quality of life after excision for vulvar intraepithelial neoplasia. J Reprod Med. 2007;52:23–7.
   PubMed Web of Science ®Google Scholar
• Thuesen B, Andreasson B, Bock JE. Sexual function and somatopsychic reactions after local excision of vulvar intra-epithelial neoplasia. Acta Obstet Gynecol Scand. 1992;71:126–8.
   PubMed Web of Science ®Google Scholar
• Likes WM, Stegbauer C, Tillmanns T, Pruett J. Correlates of sexual function following vulvar excision. Gynecol Oncol. 2007;105:600–3.
   PubMedGoogle Scholar
• Shylasree TS, Karanjgaokar V, Tristram A, Wilkes AR, MacLean AB, Fiander AN. Contribution of demographic, psychological and disease-related factors to quality of life in women with high-grade vulval intraepithelial neoplasia. Gynecol Oncol. 2008;110:185–9.
   PubMed Web of Science ®Google Scholar
• Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol. 2005;106:1319–26.
   PubMed Web of Science ®Google Scholar
• Modesitt SC, Waters AB, Walton L, Fowler WC Jr, Van Le L. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet Gynecol. 1998;92:962–6.
   PubMedGoogle Scholar
• Kaufman RH. Intraepithelial neoplasia of the vulva. Gynecol Oncol. 1995;56:8–21.
   PubMedGoogle Scholar
• Schiller M, Metze D, Luger TA, Grabbe S, Gunzer M. Immune response modifiers–mode of action. Exp Dermatol. 2006;15:331–41.
   PubMed Web of Science ®Google Scholar
• Schon MP, Schon M. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis. 2004;9:291–8.
   PubMed Web of Science ®Google Scholar
• Iavazzo C, Pitsouni E, Athanasiou S, Falagas ME. Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia. Int J Gynaecol Obstet. 2008;101:3–10.
   PubMed Web of Science ®Google Scholar
• Le T, Menard C, Hicks-Boucher W, Hopkins L, Weberpals J, Fung-Kee-Fung M. Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia. Gynecol Oncol. 2007;106:579–84.
   Google Scholar
• Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study. Gynecol Oncol. 2007;107:219–22.
   PubMed Web of Science ®Google Scholar
• van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med. 2008;358:1465–73.
   PubMed Web of Science ®Google Scholar
• Todd RW, Steele JC, Etherington I, Luesley DM. Detection of CD8+ T cell responses to human papillomavirus type 16 antigens in women using imiquimod as a treatment for high-grade vulval intraepithelial neoplasia. Gynecol Oncol. 2004;92:167–74.
   PubMed Web of Science ®Google Scholar
• van Poelgeest MI, van Seters M, van Beurden M, Kwappenberg KM, Heijmans-Antonissen C, Drijfhout JW, Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment. Clin Cancer Res. 2005;11:5273–80.
   PubMed Web of Science ®Google Scholar
• Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125–43.
   PubMed Web of Science ®Google Scholar
• Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res. 2001;61:192–6.
   PubMed Web of Science ®Google Scholar
• Fehr MK, Hornung R, Degen A, Schwarz VA, Fink D, Haller U, Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med. 2002;30:273–9.
   PubMed Web of Science ®Google Scholar
• Hillemanns P, Untch M, Dannecker C, Baumgartner R, Stepp H, Diebold J, Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer. 2000;85:649–53.
   PubMed Web of Science ®Google Scholar
• Kurwa HA, Barlow RJ, Neill S. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy. Br J Dermatol. 2000;143:1040–2.
   PubMed Web of Science ®Google Scholar
• Martin-Hirsch P, Kitchener HC, Hampson IN. Photodynamic therapy of lower genital tract neoplasia. Gynecol Oncol. 2002;84:187–9.
   Google Scholar
• Zawislak A, Donnelly RF, McCluggage WG, Price JH, McClelland HR, Woolfson AD, Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid. Photodiagnosis Photodynamic Ther. 2009;6:28–40.
   Google Scholar
• Hillemanns P, Wang X, Staehle S, Michels W, Dannecker C. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol. 2006;100:271–5.
   PubMed Web of Science ®Google Scholar
• Winters U, Daayana S, Lear JT, Tomlinson AE, Elkord E, Stern PL, Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res. 2008;14:5292–9.
   PubMed Web of Science ®Google Scholar
• Davidson EJ, Boswell CM, Sehr P, Pawlita M, Tomlinson AE, McVey RJ, Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins. Cancer Res. 2003;63:6032–41.
   PubMed Web of Science ®Google Scholar
• Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res. 2003;9:5205–13.
   PubMed Web of Science ®Google Scholar
• Davidson EJ, Faulkner RL, Sehr P, Pawlita M, Smyth LJ, Burt DJ, Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7). Vaccine. 2004;22:2722–9.
   PubMed Web of Science ®Google Scholar
• Smyth LJ, Van Poelgeest MI, Davidson EJ, Kwappenberg KM, Burt D, Sehr P, Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination. Clin Cancer Res. 2004;10:2954–61.
   PubMed Web of Science ®Google Scholar
• Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia. N Engl J Med. 2009;361:1838–47.
   PubMed Web of Science ®Google Scholar
• Naik R, Nixon S, Lopes A, Godfrey K, Hatem MH, Monaghan JM. A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. Int J Gynecol Cancer. 2006;16:786–90.
   PubMed Web of Science ®Google Scholar
• Spirtos NM, Smith LH, Teng NN. Prospective randomized trial of topical alpha-interferon (alpha-interferon gels) for the treatment of vulvar intraepithelial neoplasia III. Gynecol Oncol. 1990;37:34–8.
   PubMed Web of Science ®Google Scholar
• Tristram A, Fiander A. Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia. Gynecol Oncol. 2005;99:652–5.
   PubMed Web of Science ®Google Scholar
• Vilmer C, Havard S, Cavelier-Balloy B, Pelisse M, Dubertret L, Leibowitch M. Failure of isotretinoin and interferon-alpha combination therapy for HPV-linked severe vulvar dysplasia. A report of two cases. J Reprod Med. 1998;43:693–5.
   Google Scholar
• Sillman FH, Sedlis A, Boyce JG. A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil. Obstet Gynecol Surv. 1985;40:190–220.
   Google Scholar
• van Beurden M, van Der Vange N, ten Kate FJ, de Craen AJ, Schilthuis MS, Lammes FB. Restricted surgical management of vulvar intraepithelial neoplasia 3: Focus on exclusion of invasion and on relief of symptoms. Int J Gynecol Cancer. 1998;8:73–7.
   PubMed Web of Science ®Google Scholar
• Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007;369:1693–702.
   PubMed Web of Science ®Google Scholar
• Jones RW, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol. 2008;198:496 e1–3.
   Google Scholar
• Santegoets LA, Seters M, Helmerhorst TJ, Heijmans-Antonissen C, Hanifi-Moghaddam P, Ewing PC, HPV related VIN: highly proliferative and diminished responsiveness to extracellular signals. Int J Cancer. 2007;121:759–66.
   Google Scholar
• Polterauer S, Catharina Dressler A, Grimm C, Seebacher V, Tempfer C, Reinthaller A, Accuracy of preoperative vulva biopsy and the outcome of surgery in vulvar intraepithelial neoplasia 2 and 3. Int J Gynecol Pathol. 2009;28:559–62.
   Google Scholar
• Chafe W, Richards A, Morgan L, Wilkinson E. Unrecognized invasive carcinoma in vulvar intraepithelial neoplasia (VIN). Gynecol Oncol. 1988;31:154–65.
   PubMed Web of Science ®Google Scholar
• Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol. 1994;84:741–5.
   PubMed Web of Science ®Google Scholar
• Rouzier R, Morice P, Haie-Meder C, Lhomme C, Avril MF, Duvillard P, Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas. Gynecol Oncol. 2001;81:414–9.
   Google Scholar
• Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol. 1999;180:24–7.
   Google Scholar
• Niikura H, Yoshida H, Ito K, Takano T, Watanabe H, Aiba S, Paget's disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution. Int J Gynecol Cancer. 2006;16:1212–5.
   Google Scholar
• Pierie JP, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg. 2003;196:45–50.
   PubMed Web of Science ®Google Scholar
• Piura B, Rabinovich A, Dgani R. Extramammary Paget's disease of the vulva: report of five cases and review of the literature. Eur J Gynaecol Oncol. 1999;20:98–101.
   Google Scholar
• Tebes S, Cardosi R, Hoffman M. Paget's disease of the vulva. Am J Obstet Gynecol. 2002;187:281–3; discussion 3–4.
   PubMed Web of Science ®Google Scholar
• Shaco-Levy R, Bean SM, Vollmer RT, Papalas JA, Bentley RC, Selim MA, Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course. Int J Gynecol Pathol. 2010;29:69–78.
   Google Scholar
• Crawford D, Nimmo M, Clement PB, Thomson T, Benedet JL, Miller D, Prognostic factors in Paget's disease of the vulva: a study of 21 cases. Int J Gynecol Pathol. 1999;18:351–9.
   PubMedGoogle Scholar
• Goldblum JR, Hart WR. Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol. 1997;21:1178–87.
   PubMed Web of Science ®Google Scholar
• Regauer S. Extramammary Paget's disease–a proliferation of adnexal origin? Histopathology. 2006;48:723–9.
   Google Scholar
• Teixeira MR, Kristensen GB, Abeler VM, Heim S. Karyotypic findings in tumors of the vulva and vagina. Cancer Genet Cytogenet. 1999;111:87–91.
   Google Scholar
• Brown HM, Wilkinson EJ. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum Pathol. 2002;33:545–8.
   PubMed Web of Science ®Google Scholar
• Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol. 2002;33:549–54.
   PubMed Web of Science ®Google Scholar
• Saito A, Sawaizumi M, Matsumoto S, Takizawa K. Stepladder V-Y advancement medial thigh flap for the reconstruction of vulvoperineal region. J Plast Reconstr Aesthet Surg. 2009;62:e196–9.
   Google Scholar
• Hatch KD, Davis JR. Complete resolution of Paget disease of the vulva with imiquimod cream. J Low Genit Tract Dis. 2008;12:90–4.
   PubMed Web of Science ®Google Scholar
• Sendagorta E, Herranz P, Feito M, Ramirez P, Floristan U, Feltes R, Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod–proposal of a therapeutic schedule. J Eur Acad Dermatol Venereol. 2009;24:490–2.
   Google Scholar
• Wang LC, Blanchard A, Judge DE, Lorincz AA, Medenica MM, Busbey S. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream. J Am Acad Dermatol. 2003;49:769–72.
   PubMed Web of Science ®Google Scholar
• Fukui T, Watanabe D, Tamada Y, Matsumoto Y. Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget's disease. Acta Derma Venereol. 2009;89:150–4.
   PubMed Web of Science ®Google Scholar
• Raspagliesi F, Fontanelli R, Rossi G, Ditto A, Solima E, Hanozet F, Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study. Gynecol Oncol. 2006;103:581–6.
   PubMed Web of Science ®Google Scholar
• Shaco-Levy R, Bean SM, Vollmer RT, Jewell E, Jones EL, Valdes CL, Paget disease of the vulva: a study of 56 cases. Eur J Obstet Gynecol Reprod Biol. 2010;149:86–91.
   Google Scholar
• Karam A, Berek JS, Stenson A, Rao J, Dorigo O. HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review. Gynecol Oncol. 2008;111:568–71.
   PubMed Web of Science ®Google Scholar
• Plaza JA, Torres-Cabala C, Ivan D, Prieto VG. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J Cutan Pathol. 2009;36:729–33.
   Google Scholar
• Preti M, Micheletti L, Massobrio M, Ansai SI, Wilkinson EJ. Vulvar Paget disease: one century after first reported. J Low Genit Tract Dis. 2003;7:122–35.
   Google Scholar
• Gunn RA, Gallager HS. Vulvar Paget's disease: a topographic study. Cancer. 1980;46:590–4.
   Google Scholar
• Black D, Tornos C, Soslow RA, Awtrey CS, Barakat RR, Chi DS. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva. Gynecol Oncol. 2007;104:547–50.
   Google Scholar
• Kingston NJ, Jones RW, Baranyai J. Recurrent primary vulvovaginal malignant melanoma arising in melanoma in situ–the natural history of lesions followed for 23 years. Int J Gynecol Cancer. 2004;14:628–32.
   Google Scholar
• Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292:2771–6.
   PubMed Web of Science ®Google Scholar
• Tran KT, Wright NA, Cockerell CJ. Biopsy of the pigmented lesion–when and how. Journal of the American Academy of Dermatology. 2008;59:852–71.
   PubMedGoogle Scholar
• ACOG Practice Bulletin No.93: diagnosis and management of vulvar skin disorders. Obstet Gynecol. 2008;111:1243–53.
   PubMedGoogle Scholar
• Bartoli C, Bono A, Clemente C, Del Prato ID, Zurrida S, Cascinelli N. Clinical diagnosis and therapy of cutaneous melanoma in situ. Cancer. 1996;77:888–92.
   Google Scholar
• Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.
   PubMed Web of Science ®Google Scholar
• Sober AJ, Balch CM. Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol. 2007;14:274–5.
   Google Scholar
• Dummer R, Hauschild A, Jost L. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(Suppl 2):ii86–8.
   PubMedGoogle Scholar
• Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res. 2008;18:61–7.
   PubMed Web of Science ®Google Scholar